Aline Sherwood
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Aline B. Sherwood worked as Senior Director-Strategic Communications at Cognition Therapeutics, Inc. from 2023 to 2025.
Served as Independent Director at Bio-Path Holdings, Inc. from 2022 to 2025.
Held the position of Head-Communications at The Liposome Co., Inc. Owned Scienta Communications LLC.
Completed undergraduate education at Beloit College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.03.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2025 |
| BIO-PATH HOLDINGS, INC. | Direktor/Vorstandsmitglied | 21.06.2025 |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Public Communications Contact | - |
Scienta Communications LLC | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Health Technology |
Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company, which focuses on developing therapeutic products | Health Technology |
Beloit College
Beloit College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Scienta Communications LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen